Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

 
 
 
 
 
    Displaying results 1 - 20 of 41
  • 1
  • 2
  • 3
  • »
Founded in 2019, this inclusive lab is comprised of 42 members ranging from undergraduates to faculty from 12 different countries, most of whom self-identify as women and/or individuals who are under-represented in medicine.
In this podcast, Joy Larsen Haidle, Genetic Counselor at North Memorial Health Cancer Center in Robbinsdale, Minnesota, and Lillie Shockney, University Distinguished Service Professor of Breast Cancer, Professor of Surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland, delve into the topic of BRCA mutation testing within breast cancer care, highlighting care gaps and opportunities …
ACCC was invited to share the association’s key priorities for impacting cancer care in the US. ACCC president Olalekan Ajayi, PharmD, MBA, and chief operating officer at Highlands Oncology Group, PA, discusses the meeting and these initiatives.
Live this week from the ACCC 40th National Oncology Conference, CANCER BUZZ interviews Dr. Michael Gieske about best practices to increase lung cancer screenings and ACCC’s Rural Appalachian Lung Screening Initiative.
CANCER BUZZ previews the sessions, people and topics of this week’s ACCC 40th National Oncology Conference. We interview Kathy Oubre, MS, CEO of the Pontchartrain Canter Center, about helping patients overcome access barriers to biomarker testing.
Disparities in bladder cancer care persist, especially with respect to race. In fact, patient demographics has a proven impact on health outcomes. Listen in as CancerBuzz speaks to Mary W. Dunn, MSN, RN, OCN, NP-C, Adult Nurse Practitioner of Urology and Medical Oncology at the UNC Lineberger Comprehensive Cancer Center and Samuel L. Washington III, MD, MAS, Assistant Professor of Urology at the University …
In this episode, CANCER BUZZ speaks with Farrukh T. Awan, MD, MS, professor of Internal Medicine and director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, about their approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.
Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment criteria and trial selection.
The rapid evolution of cancer care delivery toward multi-agent regimens, oral and/or combination therapies, and at-home treatment administration has made cancer caregiving extremely complex. The Caregiver Clinic at Memorial Sloan Kettering provides support to people who are having difficulty coping with the demands of being a caregiver. The purpose of this clinic is to help individuals maximize their …
For several years, this healthcare system struggled to find a sustainable program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.
As community care teams work to provide equitable care for patients with chronic lymphocytic leukemia (CLL), understanding disparities as well as state and region-specific barriers that impact care is critical.
Learn about population health navigators—individuals dedicated to supporting a specific underserved population, including rural, Black, and Latinx populations, through culturally and linguistically competent navigation services for patients with cancer, their families, and their caregivers.
To celebrate its 100th episode, CANCER BUZZ talks to ACCC Board Member and Treasurer Dr. Nadine Barrett about her journey with the Association of Community Cancer Centers.
Remote patient monitoring transmits health data from the patient’s home to healthcare providers. This quality improvement project evaluated a platform to remotely monitor Black and Latinx patients.
In this episode, Dr. Noel breaks down how to build trust and earn the respect of under-represented patient populations in the community.
Allowing APPs (e.g., nurse practitioners and physician assistants) the privilege to sign anti-cancer treatment orders not only improves access to high-quality cancer care, it can also free up physician time to see more new patients and streamline clinic workflow.
At the height of the pandemic, many people were actively avoiding hospitals. The concern: during this extended period of time, there could be delays in cancer detection and treatment rates. The James Cancer Hospital opened a new set of front doors to its facility, The James Cancer Diagnostic Center, where patients can be evaluated, diagnosed, and treated all under one roof.
Baptist Health South Florida, Miami Cancer Institute in Florida turned to technology to provide high-quality cancer care without having to dip deeper into its operating budget.
Since implementation, Chemotherapy Care Companion has decreased patients’ healthcare costs by preventing emergency department (ED) visits and hospitalizations and improved their overall satisfaction.
Hear about a treatment plan collaboration between the oncology care team and PCP from one of our 2022 ACCC Innovator Award winners—ChristianaCare's Helen F. Graham Cancer Center & Research Institute.
    Displaying results 1 - 20 of 41
  • 1
  • 2
  • 3
  • »
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.